Jubilant HollisterStier has entered into a multi-year contract with a major U.S. pharma company to manufacture an OTC women’s health product. The contract has a total value of more than $70 million for a four-year period, with a possibility of a two-year extension. Production of the product began earlier this month at the company’s manufacturing facility in Montreal, Canada.

Shyam S. Bhartia, chairman and managing director, and Hari S Bhartia, co-chairman and managing director, Jubilant Life Sciences Ltd., said, “This contract is an outcome of our strategy to expand our offerings across products and geographies. We are happy to extend our CMO services for an OTC women health product with a leading customer in North America. Over the years we have successfully helped provide safe and effective products to consumers and are committed to do so for this product as well. ”